Intellimedix, a company devoted to developing and applying novel methods to accelerate the discovery of new treatments and cures, with a focus on epilepsy and other neurological disorders, joined with the Massachusetts Life Sciences Center (MLSC), MassBio and DivcoWest Real Estate Investments to host a grand opening and ribbon cutting ceremony to officially open their new research lab in Cambridge, MA. The new facility is located at One Kendall Square.